According to a new research, controlling of intensive blood sugar decreases the eventual risk of developing eye diseases in people with type 2 diabetes. It was earlier found that people with type 2 diabetes are in danger of developing diabetic retinopathy, an unique condition that ruins our tiny blood vessels in the retina. These blood vessels are the light sensitive tissues in our eye.
This study researcher group conducted a survey that measures type 2 diabetes patients based on how regularly they have received intensive therapy or standard therapy to decrease controlled blood sugar. The study judged people based on their performance of hemoglobin A1C tests. This test checks results of many months of blood sugar levels.
According to the U.S. National Institute of Diabetes and Digestive and Kidney Disease, People are generally recognized with diabetes when their A1C is 6.5 percent or much higher than that. People with type 2 diabetes aims to have an A1C under 7 percent. However, the target can be flexible based on the physical activity of someone.
The study marked that people with intensive therapy had average hemoglobin A1C levels of 6.4 percents in the end. This study recorded the health condition of participant’s eye for four years. Researchers found that the deadly risk of advancing diabetic retinopathy for patients in the intensive therapy group was though 6 percent, when it came to standard therapy group, the rate was about 13 percent.
Principal author Dr. Emily Chew from the study team stated “This study sends a powerful message to people with type 2 diabetes who worry about losing vision,” Dr. Emily is the deputy director of epidemiology and clinical applications at the U.S. National Eye Institute. Dr Emily further stated regarding the findings “Well-controlled [blood sugar] has a positive, measurable and lasting effect on eye health,”.
A horrific number of 8 million people have developed diabetic eye disease in the United States. Among the many consequences, eye condition due to diabetes is one of the main reasons of vision loss in Americans. The findings of this study will be presented at the American Diabetes Association’s annual meeting. The meeting will be held on New Orleans.